Related Experiment Videos
Pre-exposure rabies immunization of man with suckling mouse brain vaccine
Abstract:
A case series study is reported which included serologic results obtained in 195 persons recruited from personnel and trainees of the Pan American Zoonoses Center in Buenos Aires, Argentina, and workers from other institutions. The individuals were vaccinated with three doses of suckling mouse brain vaccine administered on alternate days, and some of them were given a booster dose 30 or 365 days after the primary immunization. The sizeable percentage of reactors with a high neutralizing antibody response in a short period of time, the small number of persons requiring a booster dose 30 days after the first vaccine dose, the rapid and intense secondary immune response and the absence of serious post-vaccinal reactions justify encouraging the use of this abbreviated prophylactic course of suckling mouse brain vaccine.
Insights
This study found that an abbreviated prophylactic course of suckling mouse brain vaccine induced a strong immune response. The vaccine demonstrated efficacy with minimal need for booster doses and no serious adverse reactions.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- The study investigated the immunogenicity and safety of a suckling mouse brain vaccine.
- Previous vaccination protocols may have been lengthy or associated with adverse reactions.
Purpose of the Study:
- To evaluate the effectiveness of an abbreviated vaccination schedule using suckling mouse brain vaccine.
- To assess the serologic response and safety profile of the vaccine.
Main Methods:
- A case series of 195 individuals receiving three doses of suckling mouse brain vaccine on alternate days.
- Some participants received a booster dose at 30 or 365 days post-primary immunization.
- Serologic testing was performed to measure neutralizing antibody responses.
Main Results:
- A significant percentage of individuals showed a high neutralizing antibody response shortly after vaccination.
- Few participants required a booster dose 30 days after primary immunization.
- A rapid and robust secondary immune response was observed, with no serious post-vaccinal reactions.
Conclusions:
- The abbreviated prophylactic course of suckling mouse brain vaccine is effective and well-tolerated.
- The findings support the use of this shortened vaccination schedule for public health initiatives.
- The vaccine elicits a strong and rapid immune response, justifying its abbreviated application.